Long-term 52-week results of PALACE 3, a phase 3, randomized controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement

BLANCO GARCIA, FRANCISCO JAVIER

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/8478

ISSN: 0300-9742

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2014

Journal title

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Type of content

Publicación de congreso